NEA leads Series A round for Reneo Pharmaceuticals

San Diego-based Reneo Pharmaceuticals, a clinical-stage pharmaceutical company, has raised $50 million in Series A financing. New Enterprise Associates led the round.

20 May 2019•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail